PortfoliosLab logo
HRTS vs. SCHD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between HRTS and SCHD is 0.56, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.6

Performance

HRTS vs. SCHD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema Obesity & Cardiometabolic ETF (HRTS) and Schwab US Dividend Equity ETF (SCHD). The values are adjusted to include any dividend payments, if applicable.

0.00%5.00%10.00%15.00%20.00%25.00%30.00%NovemberDecember2025FebruaryMarchApril
8.88%
14.73%
HRTS
SCHD

Key characteristics

Sharpe Ratio

HRTS:

-0.38

SCHD:

0.18

Sortino Ratio

HRTS:

-0.38

SCHD:

0.36

Omega Ratio

HRTS:

0.95

SCHD:

1.05

Calmar Ratio

HRTS:

-0.30

SCHD:

0.18

Martin Ratio

HRTS:

-0.68

SCHD:

0.63

Ulcer Index

HRTS:

11.30%

SCHD:

4.49%

Daily Std Dev

HRTS:

20.34%

SCHD:

16.01%

Max Drawdown

HRTS:

-25.81%

SCHD:

-33.37%

Current Drawdown

HRTS:

-19.25%

SCHD:

-11.06%

Returns By Period

In the year-to-date period, HRTS achieves a -1.04% return, which is significantly higher than SCHD's -4.75% return.


HRTS

YTD

-1.04%

1M

-3.05%

6M

-13.52%

1Y

-6.19%

5Y*

N/A

10Y*

N/A

SCHD

YTD

-4.75%

1M

-6.49%

6M

-7.26%

1Y

3.70%

5Y*

12.33%

10Y*

10.39%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


HRTS vs. SCHD - Expense Ratio Comparison

HRTS has a 0.75% expense ratio, which is higher than SCHD's 0.06% expense ratio.


Expense ratio chart for HRTS: current value is 0.75%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
HRTS: 0.75%
Expense ratio chart for SCHD: current value is 0.06%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
SCHD: 0.06%

Risk-Adjusted Performance

HRTS vs. SCHD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HRTS
The Risk-Adjusted Performance Rank of HRTS is 88
Overall Rank
The Sharpe Ratio Rank of HRTS is 77
Sharpe Ratio Rank
The Sortino Ratio Rank of HRTS is 77
Sortino Ratio Rank
The Omega Ratio Rank of HRTS is 77
Omega Ratio Rank
The Calmar Ratio Rank of HRTS is 66
Calmar Ratio Rank
The Martin Ratio Rank of HRTS is 1010
Martin Ratio Rank

SCHD
The Risk-Adjusted Performance Rank of SCHD is 3535
Overall Rank
The Sharpe Ratio Rank of SCHD is 3535
Sharpe Ratio Rank
The Sortino Ratio Rank of SCHD is 3434
Sortino Ratio Rank
The Omega Ratio Rank of SCHD is 3434
Omega Ratio Rank
The Calmar Ratio Rank of SCHD is 3838
Calmar Ratio Rank
The Martin Ratio Rank of SCHD is 3636
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HRTS vs. SCHD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema Obesity & Cardiometabolic ETF (HRTS) and Schwab US Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for HRTS, currently valued at -0.38, compared to the broader market-1.000.001.002.003.004.00
HRTS: -0.38
SCHD: 0.18
The chart of Sortino ratio for HRTS, currently valued at -0.38, compared to the broader market-2.000.002.004.006.008.00
HRTS: -0.38
SCHD: 0.36
The chart of Omega ratio for HRTS, currently valued at 0.95, compared to the broader market0.501.001.502.002.50
HRTS: 0.95
SCHD: 1.05
The chart of Calmar ratio for HRTS, currently valued at -0.30, compared to the broader market0.002.004.006.008.0010.0012.00
HRTS: -0.30
SCHD: 0.18
The chart of Martin ratio for HRTS, currently valued at -0.68, compared to the broader market0.0020.0040.0060.00
HRTS: -0.68
SCHD: 0.63

The current HRTS Sharpe Ratio is -0.38, which is lower than the SCHD Sharpe Ratio of 0.18. The chart below compares the historical Sharpe Ratios of HRTS and SCHD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchApril
-0.38
0.18
HRTS
SCHD

Dividends

HRTS vs. SCHD - Dividend Comparison

HRTS's dividend yield for the trailing twelve months is around 1.64%, less than SCHD's 4.03% yield.


TTM20242023202220212020201920182017201620152014
HRTS
Tema Obesity & Cardiometabolic ETF
1.64%1.62%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SCHD
Schwab US Dividend Equity ETF
4.03%3.64%3.49%3.39%2.78%3.16%2.98%3.06%2.63%2.89%2.97%2.63%

Drawdowns

HRTS vs. SCHD - Drawdown Comparison

The maximum HRTS drawdown since its inception was -25.81%, smaller than the maximum SCHD drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for HRTS and SCHD. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-19.25%
-11.06%
HRTS
SCHD

Volatility

HRTS vs. SCHD - Volatility Comparison

The current volatility for Tema Obesity & Cardiometabolic ETF (HRTS) is 10.15%, while Schwab US Dividend Equity ETF (SCHD) has a volatility of 11.23%. This indicates that HRTS experiences smaller price fluctuations and is considered to be less risky than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%NovemberDecember2025FebruaryMarchApril
10.15%
11.23%
HRTS
SCHD